Emerging role of interleukin-13 in cardiovascular diseases: A ray of hope

Area of Science:

• Cardiology
• Immunology
• Molecular Biology

Background:

• Cardiovascular diseases (CVDs) remain a leading cause of mortality despite treatment advancements.
• Inflammation is a key factor in heart injury, but its molecular mechanisms in CVDs are not fully understood.
• Interleukin-13 (IL-13), a known mediator in allergic conditions, is increasingly recognized for its role in cardiac pathology.

Purpose of the Study:

• To review current knowledge on the regulation and function of IL-13 in cardiovascular diseases.
• To explore the potential mechanisms by which IL-13 influences CVD development and progression.
• To evaluate IL-13 as a therapeutic target for CVD immunotherapy.

Main Methods:

• Literature review of studies investigating IL-13 in cardiovascular contexts.
• Analysis of research on IL-13's molecular functions and regulatory pathways.
• Synthesis of findings related to IL-13's involvement in various CVDs, including myocarditis, myocardial infarction, and heart failure.

Main Results:

• IL-13 is implicated in inflammatory heart diseases like myocarditis.
• Evidence suggests IL-13 is relevant to CVDs of diverse origins, such as myocardial infarction and heart failure.
• The precise molecular basis of IL-13's action in the heart requires further elucidation.

Conclusions:

• IL-13 is a critical cytokine involved in the pathophysiology of cardiovascular diseases.
• Understanding IL-13's role offers insights into the inflammatory mechanisms underlying heart conditions.
• IL-13 presents a promising target for developing novel immunotherapies for CVDs.